Genetic analysis of the human papillomavirus type 31 differentiation- dependent late promoter

Journal of Virology

Volumn 79, Issue 6, 2005, Pages 3309-3321

  Bodily, Jason M ^a   Meyers, Craig ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; PROTEIN KINASE C INHIBITOR; VIRUS DNA;

ARTICLE; CELL DIFFERENTIATION; GENE AMPLIFICATION; GENE CONTROL; GENE MAPPING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN PAPILLOMA VIRUS TYPE 31; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; VIRAL GENETICS; WART VIRUS;

CELLS, CULTURED; ENHANCER ELEMENTS (GENETICS); ENZYME INHIBITORS; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HUMANS; INDOLES; MALEIMIDES; PAPILLOMAVIRIDAE; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; VIRAL STRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 14744269924     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.6.3309-3321.2005     Document Type: Article

References (67)

1. Ai, W., J. Narahari, and A. Roman. 2000. Yin yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6. J. Virol. 74:5198-5205.
2. Andersen, B., M. D. Schonemann, S. E. Flynn, R. V. Pearse, 2nd, H. Singh, and M. G. Rosenfeld. 1993. Skn-1a and Skn-1i: two functionally distinct Oct-2-related factors expressed in epidermis. Science 260:78-82.
3. Andersen, B., W. C. Weinberg, O. Rennekampff, R. J. McEvilly, J. R. Bermingham, Jr., F. Hooshmand, V. Vasilyev, J. F. Hansbrough, M. R. Pittelkow, S. H. Yuspa, and M. G. Rosenfeld. 1997. Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. Genes Dev. 11:1873-1884.
4. Ayer, D. E., and W. S. Dynan. 1988. Simian virus 40 major late promoter: a novel tripartite structure that includes intragenic sequences. Mol. Cell. Biol. 8:2021-2033.
5. Barksdale, S., and C. C. Baker. 1995. Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs. J. Virol. 69:6553-6556.
6. Bedell, M. A., J. B. Hudson, T. R. Golub, M. E. Turyk, M. Hosken, G. D. Wilbanks, and L. A. Laimins. 1991. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 65:2254-2260.
7. Benoist, C., and P. Chambon. 1981. In vivo sequence requirements of the SV40 early promoter region. Nature 290:304-310.
8. Bourachot, B., M. Yaniv, and P. Herbomel. 1989. Control elements situated downstream of the major transcriptional start site are sufficient for highly efficient polyomavirus late transcription. J. Virol. 63:2567-2577.
9. Bream, G. L., P. Vaillancourt, and M. R. Botchan. 1992. A constitutive enhancer in the bovine papillomavirus upstream regulatory region shares genetic elements with the viral P1 promoter. J. Virol. 66:7319-7327.
10. Bromberg-White, J. L., and C. Meyers. 2003. Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines. Virology 306:197-202.
11. Bromberg-White, J. L., and C. Meyers. 2002. The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction. J. Virol. 76:9702-9715.
12. Chen, W., and K. Struhl. 1985. Yeast mRNA initiation sites are determined primarily by specific sequences, not by the distance from the TATA element. EMBO J. 4:3273-3280.
13. Cohen, R. B., L. Yang, J. A. Thompson, and B. Safer. 1988. Identification of a downstream sequence and binding protein that regulate adenovirus major late promoter transcription in vitro. J. Biol. Chem. 263:10377-10385.
14. Cornwell, M. M. 1990. The human multidrug resistance gene: sequences upstream and downstream of the initiation site influence transcription. Cell Growth Differ. 1:607-615.
15. Crook, T., D. Wrede, and K. H. Vousden. 1991. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6:873-875.
16. del Mar Pena, L. M., and L. A. Laimins. 2001. Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression. J. Virol. 75:10005-10013.
17. Farnham, P. J., and A. L. Means. 1990. Sequences downstream of the transcription initiation site modulate the activity of the murine dihydrofolate reductase promoter. Mol. Cell. Biol. 10:1390-1398.
18. Flores, E. R., B. L. Allen-Hoffmann, D. Lee, and P. F. Lambert. 2000. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J. Virol. 74:6622-6631.
19. Flores, E. R., and P. F. Lambert. 1997. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J. Virol. 71:7167-7179.
20. Frattini, M. G., and L. A. Laimins. 1994. The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b. Virology 204:799-804.
21. Gong, S. S., and K. N. Subramanian. 1988. Functional anatomy of the simian virus 40 late promoter. Virology 163:481-493.
22. Grassmann, K., B. Rapp, H. Maschek, K. U. Petry, and T. Iftner. 1996. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 70:2339-2349.
23. Guhaniyogi, J., and G. Brewer. 2001. Regulation of mRNA stability in mammalian cells. Gene 265:11-23.
24. Hashimoto-Gotoh, T., R. Kikuno, M. Takahashi, and H. Honkawa. 1988. Possible role of the first intron of c-H-ras in gene expression: anti-cancer elements in oncogenes. Anticancer Res. 8:851-859.
25. Hubert, W. G., T. Kanaya, and L. A. Laimins. 1999. DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5′ of the minimal origin. J. Virol. 73:1835-1845.
26. Hummel, M., J. B. Hudson, and L. A. Laimins. 1992. Differentiation- induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66:6070-6080.
27. Hummel, M., H. B. Lim, and L. A. Laimins. 1995. human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing. J. Virol. 69:3381-3388.
28. Jenson, B., and W. Lancaster. 1990. Association of human papillomaviruses with benign, premalignant, and malignant anogenital lesions, p. 11-43. In H. Pfister (ed.), Papillomaviruses and human cancer. CRC Press, Boca Raton, Fla.
29. Kadonaga, J. T. 2002. The DPE, a core promoter element for transcription by RNA polymerase II. Exp. Mol. Med. 34:259-264.
30. Kanaya, T., S. Kyo, and L. A. Laimins. 1997. The 5′ region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1. Virology 237:159-169.
31. Keller, J. M., and J. C. Alwine. 1984. Activation of the SV40 late promoter: direct effects of T antigen in the absence of viral DNA replication. Cell 36:381-389.
32. Klumpp, D. J., and L. A. Laimins. 1999. Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1. Virology 257:239-246.
33. Kotova, I., A. L. Chabes, S. Lobov, L. Thelander, and S. Bjorklund. 2003. Sequences downstream of the transcription initiation site are important for proper initiation and regulation of mouse ribonucleotide reductase R2 gene transcription. Eur. J. Biochem. 270:1791-1801.
34. Kukimoto, I., and T. Kanda. 2001. Displacement of YY1 by differentiation-specific transcription factor hSkn-1a activates the P(670) promoter of human papillomavirus type 16. J. Virol. 75:9302-9311.
35. Kyo, S., A. Tam, and L. A. Laimins. 1995. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors. Virology 211:184-197.
36. Lu, J., W. Lee, C. Jiang, and E. B. Keller. 1994. Start site selection by Sp1 in the TATA-less human Ha-ras promoter. J. Biol. Chem. 269:5391-5402.
37. Mack, D. H., J. Vartikar, J. M. Pipas, and L. A. Laimins. 1993. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 363:281-283.
38. McCready, P. M., R. K. Hansen, S. L. Burke, and J. F. Sands. 1997. Multiple negative and positive cis-acting elements control the expression of the murine CD4 gene. Biochim. Biophys. Acta 1351:181-191.
39. McLaughlin-Drubin, M. E., and C. Meyers. 2004. Evidence for the coexistence of two genital HPV types within the same host cell in vitro. Virology 321:173-180.
40. McLaughlin-Drubin, M. E., S. Wilson, B. Mullikin, J. Suzich, and C. Meyers. 2003. Human papillomavirus type 45 propagation, infection, and neutralization. Virology 312:1-7.
41. Meyers, C., J. L. Bromberg-White, J. Zhang, M. E. Kaupas, J. T. Bryan, R. S. Lowe, and K. U. Jansen. 2002. Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera. J. Virol. 76:4723-4733.
42. Meyers, C., M. G. Frattini, J. B. Hudson, and L. A. Laimins. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973.
43. Meyers, C., T. J. Mayer, and M. A. Ozbun. 1997. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 71:7381-7386.
44. Ozbun, M. A., and C. Meyers. 1997. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 71:5161-5172.
45. Ozbun, M. A., and C. Meyers. 1998. human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology 248:218-230.
46. Ozbun, M. A., and C. Meyers. 1998. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J. Virol. 72:2715-2722.
47. Pfister, H. 1990. General introduction to Papillomaviruses, p. 1-9. In H. Pfister (ed.), Papillomaviruses and human cancer. CRC Press, Boca Raton, Fla.
48. Piatak, M., K. N. Subramanian, P. Roy, and S. M. Weissman. 1981. Late messenger RNA production by viable simian virus 40 mutants with deletions in the leader region. J. Mol. Biol. 153:589-618.
49. Rapp, B., A. Pawellek, F. Kraetzer, M. Schaefer, C. May, K. Purdie, K. Grassmann, and T. Iftner. 1997. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2. J. Virol. 71:6956-6966.
50. Roeder, R. G. 1996. The role of general initiation factors in transcription by RNA polymerase II. Trends Biochem. Sci. 21:327-335.
51. Ruesch, M., F. Stubenrauch, and L. Laimins. 1998. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin 10. J. Virol. 72:5016-5024.
52. Sen, E., S. Alam, and C. Meyers. 2004. Genetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J. Virol. 78:612-629.
53. Sen, E., J. L. Bromberg-White, and C. Meyers. 2002. Genetic analysis of cis regulatory elements within the 5′ region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J. Virol. 76:4798-4809.
54. Smale, S. T. 2001. Core promoters: active contributors to combinatorial gene regulation. Genes Dev. 15:2503-2508.
55. Smale, S. T., A. Jain, J. Kaufmann, K. H. Emami, K. Lo, and I. P. Garraway. 1998. The initiator element: a paradigm for core promoter heterogeneity within metazoan protein-coding genes. Cold Spring Harb. Symp. Quant. Biol. 63:21-31.
56. Somasekhar, M. B., and J. E. Mertz. 1985. Sequences involved in determining the locations of the 5′ ends of the late RNAs of simian virus 40. J. Virol. 56:1002-1013.
57. Steele, B. K., C. Meyers, and M. A. Ozbun. 2002. Variable expression of some "housekeeping" genes during human keratinocyte differentiation. Anal. Biochem. 307:341-347.
58. Stoler, M. H., S. M. Wolinsky, A. Whitbeck, T. R. Broker, and L. T. Chow. 1989. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172:331-340.
59. Terhune, S. S., C. Milcarek, and L. A. Laimins. 1999. Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle. J. Virol. 73:7185-7192.
60. Tibudan, S. S., Y. Wang, and M. F. Denning. 2002. Activation of protein kinase C triggers irreversible cell cycle withdrawal in human keratinocytes. J. Investig. Dermatol. 119:1282-1289.
61. Tommasino, M., and P. Jansen-Durr. 1997. E7 protein, p. 103-136. In M. Tommasino (ed.), Papillomaviruses in human cancer: the role of E6 and E7 oncoproteins. Landes Bioscience, Austin, Tex.
62. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, et al. 1991. The bisin-dolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771-15781.
63. Yoshida, T., and T. Sakai. 2004. Promoter of TRAIL-R2 gene. Vitam. Horm. 67:35-49.
64. Zhao, W., L. T. Chow, and T. R. Broker. 1999. A distal element in the HPV-11 upstream regulatory region contributes to promoter repression in basal keratinocytes in squamous epithelium. Virology 253:219-229.
65. zur Hausen, H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.
66. zur Hausen, H. 1996. Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta 1288:F55-78.
67. zur Hausen, H. 1999. Papillomaviruses in human cancers. Proc. Assoc. Am Physicians 111:581-587.